US Stock MarketDetailed Quotes

ADCT ADC Therapeutics

Watchlist
  • 1.960
  • -0.160-7.55%
Close Dec 20 16:00 ET
  • 2.050
  • +0.090+4.59%
Post 20:01 ET
189.51MMarket Cap-0.82P/E (TTM)

About ADC Therapeutics Company

ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.

Company Profile

SymbolADCT
Company NameADC Therapeutics
Listing DateMay 15, 2020
Issue Price19.00
Founded2011
CEOMr. Ameet Mallik
MarketNYSE
Employees274
Fiscal Year Ends12-31
AddressBiop?le,Route de la Corniche 3B
CityEpalinges
ProvinceVaud
CountrySwitzerland
Zip Code1066
Phone41-212-653-02-00
Websitehttp://www.adctherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Ameet Mallik
  • Chief Executive Officer and Director
  • 3.78M
  • Lisa Michelle Kallebo
  • Corporate Controller and Chief Accounting Officer
  • --
  • Jose Carmona
  • Chief Financial Officer
  • 1.26M
  • Mohamed Zaki, M.D.,PhD
  • Chief Medical Officer
  • 4.40M
  • Peter J. Graham
  • Chief Legal Officer
  • --
  • Ron Squarer
  • Chairman of the Board
  • 526.73K
  • Thomas Pfisterer
  • Director
  • 194.30K
  • Peter Hug, PhD
  • Lead Independent Director
  • 212.61K
  • Dr. Tyrell J. Rivers, PhD
  • Independent Director
  • --
  • Dr. Jean-Pierre Bizzari, M.D.
  • Independent Director
  • 197.81K
  • Viviane Monges
  • Independent Director
  • 231.33K
  • Dr. Victor Sandor, C.M.,M.D.
  • Independent Director
  • 227.72K
  • Robert W. Azelby
  • Independent Director
  • 127.67K
Heat List
US
Overall
Symbol
Price
% Chg

No Data